Company Overview - Citizen Health has raised $30 million in Series A funding, bringing total funding to $44 million since its launch in December 2023 [1] - The company is co-founded by Farid Vij and Nasha Fitter, who have extensive experience in AI, healthcare, and patient advocacy [2][5] - Citizen Health aims to empower patients with rare and complex conditions by providing a platform that combines AI, community, and longitudinal health data [2][10] Product and Innovation - The platform is designed to help patients interpret medical records, track symptoms, manage appointments, and connect to the next steps in their health journey [2][3] - Citizen Health plans to launch the first version of its AI Advocate in Q3, targeting select communities [8] - The company has built over 60 engaged communities across 123 rare and complex conditions and partnered with over 70 patient advocacy groups [8] Market Context - Rare diseases affect over 400 million people globally, with 95% lacking approved treatments, highlighting the urgency of Citizen Health's mission [7] - The platform addresses challenges posed by shifting NIH funding and regulatory uncertainty, aligning with recent FDA calls for innovation in rare disease [7] - As genetic testing becomes more accessible, Citizen Health's platform offers critical solutions for new disease groups seeking connection and data-driven progress [7] Partnerships and Trust - Citizen Health collaborates with over 10 pharmaceutical partners and has data accepted by the FDA for regulatory submission [8] - 98.3% of patients on the platform share data for research, indicating a high level of trust in the platform [8] - Investors like 8VC and Headline recognize the potential of Citizen Health in redefining the care model for patients with complex diseases [4][6]
Citizen Health Raises $30 Million to Build AI Advocate for Every Patient, Ushering in a New Era of Patient-Centered Healthcare